BetterLife Pharma (BETRF) Share-based Compensation Growth (5y) (2016 - 2026)
BetterLife Pharma (BETRF) Share-based Compensation Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -8.13% |
| Jul 31, 2025 | -21.80% |
| Apr 30, 2025 | -21.60% |
| Jan 31, 2025 | -21.35% |
| Oct 31, 2024 | -14.93% |
| Jul 31, 2024 | -46.86% |
| Apr 30, 2024 | 206.46% |
| Oct 31, 2023 | -4.92% |
| Jul 31, 2023 | 10.07% |
| Apr 30, 2023 | -21.17% |
| Jan 31, 2023 | 9.90% |
| Oct 31, 2022 | 188.34% |
| Jul 31, 2022 | 53.85% |
| Apr 30, 2022 | 231.09% |
| Jan 31, 2022 | 16.28% |
| Oct 31, 2021 | -20.43% |
| Jul 31, 2021 | -52.89% |
| Apr 30, 2021 | 15.51% |
| Jul 31, 2016 | 278.30% |
| Apr 30, 2016 | -250.08% |